---
title: "MRNA Analyst Ratings and Price Target - Moderna Stock Forecast | Tradytics"
description: "Moderna (MRNA) analyst ratings, the average price target and its range, and every firm's latest call."
url: "https://tradytics.com/research/MRNA/analysts"
image: "https://tradytics.com/api/v2/og/research.png?id=MRNA&v=stock-11994867"
---

# MRNA analyst estimates

Moderna (MRNA) analyst ratings, the average price target and its range, and every firm's latest call.

- 14 firms rate MRNA: 2 buy, 8 hold, 4 sell.
- The average price target is $143.67 from None analysts, from $25.00 to $305.00.

## MRNA analyst ratings and price targets

| Date | Firm | Call | Target |
| --- | --- | --- | --- |
| Nov 17, 2026 | J.P. Morgan | Moderna (MRNA) PT Raised to $102 at JPMorgan | $102.00 |
| Nov 9, 2026 | Piper Sandler | Moderna (MRNA) PT Raised to $305 at Piper Sandler | $305.00 |
| Oct 26, 2026 | Piper Sandler | Moderna price target raised to $230 from $167 at Piper Sandler | $230.00 |
| Oct 19, 2026 | Bank of America Securities | Moderna price target raised to $220 from $200 at BofA | $220.00 |
| Oct 15, 2026 | Goldman Sachs | Moderna price target raised to $137 from $120 at Goldman Sachs | $137.00 |
| Sep 3, 2026 | UBS | Moderna downgraded to Sell from Neutral at Rothschild & Co Redburn | $81.00 |
| Aug 28, 2026 | Argus Research | Argus Upgrades Moderna (MRNA) to Buy | $180.00 |
| Aug 24, 2026 | Barclays | Moderna price target raised to $125 from $48 at Barclays | $125.00 |
| Aug 20, 2026 | UBS | Moderna price target raised to $150 from $50 at UBS | $150.00 |
| Aug 19, 2026 | D.A. Davidson | DA Davidson Reiterates Neutral Rating on Lowe's (LOW) as Guidance Lowered | $245.00 |
| Aug 19, 2026 | Loop Capital Markets | Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA) Following Positive Intismeran Data | $135.00 |
| Aug 19, 2026 | RBC Capital | Moderna price target raised to $130 from $45 at RBC Capital | $130.00 |
| Aug 19, 2026 | Goldman Sachs | Moderna price target raised to $120 from $67 at Goldman Sachs | $120.00 |
| Jul 21, 2026 | Goldman Sachs | Moderna price target raised to $67 from $49 at Goldman Sachs | $67.00 |
| Jul 20, 2026 | Wolfe Research | Moderna (MRNA) PT Raised to $25 at Wolfe Research | $25.00 |

- [MRNA stock analysis](https://tradytics.com/research/MRNA)
- [MRNA options overview](https://tradytics.com/research/MRNA/options)
- [MRNA earnings](https://tradytics.com/research/MRNA/earnings)
- [MRNA financials](https://tradytics.com/research/MRNA/financials)
- [MRNA peer analysis](https://tradytics.com/research/MRNA/peers)
- [MRNA insider trading](https://tradytics.com/research/MRNA/insiders)
- [MRNA congressional trades](https://tradytics.com/research/MRNA/politicians)
- [MRNA institutional holdings](https://tradytics.com/research/MRNA/funds)
- [MRNA live chart](https://tradytics.com/charts?s=MRNA)
- [Read the data without JavaScript](https://tradytics.com/research/MRNA/analysts?snapshot=1)
